AVM Biotechnology Revenue

Biotechnology Research • Seattle, Washington, United States • 11-20 Employees

AVM Biotechnology revenue & valuation

Annual revenue	$7,500,000
Revenue per employee	$536,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$24,000,000
Total funding	$2,000,000

Key Contacts at AVM Biotechnology

Theresa Deisher

Ceo And Cso

Appu Appu

Director

Company overview

Headquarters	1749 Dexter Ave N, Seattle, Washington 98109, US
Phone number	+12069069922
Website	avmbiotech.com
NAICS	541714
SIC	873
Keywords	Personalized Medicine, Diabetes, Cancer, R&D, Drug Discovery, Immunology, Regenerative Medicine, Stem Cells, Autoimmunity, Fully Human Biologics, Non-Hodgkin Lymphoma, Natural Killer T-Cells
Founded	2008
Employees	11-20
Socials

AVM Biotechnology Email Formats

AVM Biotechnology uses 2 email formats. The most common is {first initial}{last name} (e.g., jdoe@avmbiotech.com), used 50% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@avmbiotech.com	50%
{last name}{last name}	doedoe@avmbiotech.com	50%

About AVM Biotechnology

The company's lead drug AVM0703, a proprietary innovative formulation of dexamethasone, when given at supra-pharmacologic doses has a novel mechanism of action to mobilize the body's own natural supercharged immune cells. AVM0703 triggers the production and release of endogenous gamma delta TCR+ invariant TCR+ bispecific T lymphocytes and Natural Killer T cells and could be the first choice for no-option cancer, autoimmunity, and infectious disease. AVM Biotechnology was founded by Dr. Theresa Deisher with a personal mission to defeat cancer and has a Scientific Advisory Board including well-respected leaders in cancer and immunology. The company is committed to developing products that improve outcomes without additional suffering because side effects from treatments should never be worse than the diseases themselves.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Entry

Manager

C-Suite

Employees by Department

AVM Biotechnology has 9 employees across 7 departments.

Departments

Number of employees

Funding Data

Explore AVM Biotechnology's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2022-07-14	9	$2,000,000

Funding Insights

$2,000,000

Total funding amount

$2,000,000

Most recent funding amount

Number of funding rounds

AVM Biotechnology Tech Stack

Discover the technologies and tools that power AVM Biotechnology's digital infrastructure, from frameworks to analytics platforms.

reCAPTCHA

Security

Gravity Forms

Form builders

PWA

Miscellaneous

Microsoft 365

Twitter Emoji

Font scripts

jQuery

JavaScript libraries

PHP

Programming languages

WordPress

Blogs

Google Analytics

Analytics

Yoast SEO

SEO

Google Hosted Libraries

CDN

Google Tag Manager

Tag managers

Frequently asked questions

AVM Biotechnology is located in Seattle, Washington, US.

You can reach AVM Biotechnology at +12069069922.

AVM Biotechnology generates an estimated annual revenue of $7,500,000. This revenue figure reflects the company's market position and business performance in its industry.

AVM Biotechnology has an estimated valuation of $24,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

AVM Biotechnology was founded in 2008, making it 18 years old. The company has established itself as a significant player in its industry over this time.

AVM Biotechnology has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

AVM Biotechnology has raised a total of $2,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at AVM Biotechnology

Theresa Deisher

Ceo And Cso

Appu Appu

Director

4.8

40,000 users